Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 1
2015 1
2016 2
2017 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Disorganization domain as a putative predictor of Treatment Resistant Schizophrenia (TRS) diagnosis: A machine learning approach.
Barone A, De Prisco M, Altavilla B, Avagliano C, Balletta R, Buonaguro EF, Ciccarelli M, D'Ambrosio L, Giordano S, Latte G, Matrone M, Milandri F, Francesco DN, Vellucci L, de Bartolomeis A. Barone A, et al. Among authors: balletta r. J Psychiatr Res. 2022 Nov;155:572-578. doi: 10.1016/j.jpsychires.2022.09.044. Epub 2022 Sep 29. J Psychiatr Res. 2022. PMID: 36206601
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones.
Iasevoli F, Giordano S, Balletta R, Latte G, Formato MV, Prinzivalli E, De Berardis D, Tomasetti C, de Bartolomeis A. Iasevoli F, et al. Among authors: balletta r. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Feb 4;65:34-48. doi: 10.1016/j.pnpbp.2015.08.010. Epub 2015 Aug 25. Prog Neuropsychopharmacol Biol Psychiatry. 2016. PMID: 26320028 Clinical Trial.
Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.
de Bartolomeis A, Balletta R, Giordano S, Buonaguro EF, Latte G, Iasevoli F. de Bartolomeis A, et al. Among authors: balletta r. Psychiatry Res. 2013 Dec 15;210(2):387-95. doi: 10.1016/j.psychres.2013.06.042. Epub 2013 Jul 30. Psychiatry Res. 2013. PMID: 23910239
Efficacy and clinical determinants of antipsychotic polypharmacy in psychotic patients experiencing an acute relapse and admitted to hospital stay: results from a cross-sectional and a subsequent longitudinal pilot study.
Iasevoli F, Buonaguro EF, Marconi M, Di Giovambattista E, Rapagnani MP, De Berardis D, Martinotti G, Mazza M, Balletta R, Serroni N, Di Giannantonio M, de Bartolomeis A, Valchera A. Iasevoli F, et al. Among authors: balletta r. ISRN Pharmacol. 2014 Jan 27;2014:762127. doi: 10.1155/2014/762127. eCollection 2014. ISRN Pharmacol. 2014. PMID: 24592333 Free PMC article.